Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Puma Biotechnology (PBYI)

Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
PBYI Begins Phase II Study on Alisertib Combo in Breast Cancer

Puma Biotechnology, Inc. PBYI announced that it has initiated the phase II ALISCA-Breast1 study evaluating its pipeline candidate, alisertib, for the treatment of patients with metastatic breast cancer.The...

IMCR : 32.42 (+0.25%)
PBYI : 2.96 (+4.23%)
CSTL : 29.24 (+2.78%)
SPRO : 1.1600 (-3.33%)
PBYI Beats Q3 Earnings & Revenue Estimates, Revises '24 View, Stock Up

Puma Biotechnology, Inc. PBYI reported third-quarter 2024 adjusted earnings of 45 cents per share, which beat the Zacks Consensus Estimate of 35 cents. In the year-ago quarter, the company had reported...

FOLD : 9.54 (-0.52%)
IMCR : 32.42 (+0.25%)
PBYI : 2.96 (+4.23%)
CSTL : 29.24 (+2.78%)
Puma Biotech: Q3 Earnings Snapshot

Puma Biotech: Q3 Earnings Snapshot

PBYI : 2.96 (+4.23%)
Puma Biotech: Q2 Earnings Snapshot

Puma Biotech: Q2 Earnings Snapshot

PBYI : 2.96 (+4.23%)
Puma Biotech: Q1 Earnings Snapshot

Puma Biotech: Q1 Earnings Snapshot

PBYI : 2.96 (+4.23%)
Puma Biotech: Q4 Earnings Snapshot

Puma Biotech: Q4 Earnings Snapshot

PBYI : 2.96 (+4.23%)
Puma Biotech: Q3 Earnings Snapshot

Puma Biotech: Q3 Earnings Snapshot

PBYI : 2.96 (+4.23%)
Puma Biotech: Q2 Earnings Snapshot

Puma Biotech: Q2 Earnings Snapshot

PBYI : 2.96 (+4.23%)
Five Top Companies Fighting for the Treatment of Metastatic Breast Cancer

A significant medical breakthrough is needed in the fight against metastatic breast cancer. According to the American Cancer Society, more than 3.1 million women in the United States have a history of...

LLY : 751.06 (-0.31%)
PBYI : 2.96 (+4.23%)
GILD : 89.65 (+1.15%)
IMGN : 31.23 (unch)
BCTX : 0.7450 (+23.69%)
BCT.TO : 1.06 (+24.71%)
There are Positive Developments in the Treatment of Metastatic Breast Cancer

A significant medical breakthrough is desperately needed in the fight against metastatic breast cancer. As it stands right now, metastatic breast cancer has no cure and has proven resistant to many cancer...

LLY : 751.06 (-0.31%)
PBYI : 2.96 (+4.23%)
GILD : 89.65 (+1.15%)
IMGN : 31.23 (unch)
BCTX : 0.7450 (+23.69%)
BCT.TO : 1.06 (+24.71%)

Barchart Exclusives

ELF’s Unusual Options Activity Is a Thing of Questionable Beauty
E.L.F. Beauty’s options volume on Wednesday was 7x the 30-day average. The affordable makeup and skincare company’s unusual options activity stood out as one investor questioned its revenues. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar